Autori: Coratti G*

Filtra

Data

Hammersmith Infant Neurological Examination in low-risk infants born very preterm: a longitudinal prospective study

Body mass index in type 2 spinal muscular atrophy: a longitudinal study

Nusinersen efficacy data for 24-month in type 2 and 3 spinal muscular atrophy

Revised upper limb module in type II and III spinal muscular atrophy: 24-month changes

Longitudinal Motor Functional Outcomes and Magnetic Resonance Imaging Patterns of Muscle Involvement in Upper Limbs in Duchenne Muscular Dystrophy

Motor function in type 2 and 3 SMA patients treated with Nusinersen: a critical review and meta-analysis

SMA-miRs (miR-181a-5p, -324-5p, and -451a) are overexpressed in spinal muscular atrophy skeletal muscle and serum samples

Different trajectories in upper limb and gross motor function in spinal muscular atrophy

Age related treatment effect in type II Spinal Muscular Atrophy pediatric patients treated with nusinersen

Nusinersen in pediatric and adult patients with type III spinal muscular atrophy

Torna in alto